Use of magnetic enrichment for detection of carcinoma cells in fluid specimens

Cancer

Volumn 94, Issue 1, 2002, Pages 205-211

  Kielhorn, Eric ^a   Schofield, Kevin ^a   Rimm, David L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CARCINOMA CELL; CYTODIAGNOSIS; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; EPITHELIUM CELL; FOLLOW UP; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PERITONEAL FLUID; PLEURA FLUID; PRIORITY JOURNAL;

ASCITES; CADHERINS; CARCINOMA; CYTODIAGNOSIS; EPITHELIAL CELLS; HUMANS; IMMUNOMAGNETIC SEPARATION; PERICARDIAL EFFUSION; PLEURAL EFFUSION;

EID: 0036142216     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10193     Document Type: Article

References (26)

1. Distinction between cells in serous effusions using a panel of antibodies
2. The use of immunoperoxidase panels for the cytologic diagnosis of malignancy in serous effusions
3. Immunocytochemical panel for the identification of malignant cells in serous effusions
4. Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1
5. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience anda critical review of the literature
6. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers
7. Diagnostic value of monoclonal antibody B72.3 in detecting adenocarcinoma cells in serous effusions
8. The cell adhesion molecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids
9. E-cadherin, N-cadherin, and cairetinin in pleural effusions: The good, the bad, the worthless
10. Immunocytochemistry in the differentiai diagnosis of effusions: Use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations
11. Detection and characterization of carcinoma cells in the blood
12. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction
13. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma
14. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
15. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection
16. Flow cytometric immunophenotyping of serous effusions and peritoneal washings: Comparison with immunocytochemistry and morphological findings
17. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC
18. The use of the CELLection kit in the isolation of carcinoma cells from mononuclear cell suspensions
19. A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours
20. Ber-EP4: New monoclonal antibody which distinguishes epithelia from mesothelial
21. Platelet-derived growth factor receptor immunoreactivity in mesothelioma and nonneopiastic mesothelial cells in serous effusions
22. Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulating tumor cells
23. Micrometastases in bone marrow: Prognostic indicators for pancreatic cancer
24. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients
25. Detection of micrometastases in histologically negative lymph nodes in esophageal cancer
26. Current management of epithelial ovarian carcinoma: A review